Cyberonics, Inc., has announced its Annual results for FY-2014-15. The results shows Sales of $291.6 Million up by 6.8%, and EPS increased by 21.4% to $2.44 annually. View the full earnings release here.
Earnings: Cyberonics Sales Up $CYBX Read More »
Mylan NV, has accused Teva Pharmaceutical Industries Ltd. for the Violation of U.S. Anti-trust Rules, in an acquisition deal. Teva disclosed a 1.35 percent stake in Mylan last week. Furthermore, The violated rule is not yet clarified by Mylan. View the full release here.
News: Mylan accused Teva for Trust Violation $MYL Read More »
HTG Molecular Diagnostics Inc., has announced FY-2015 first quarter results. The results shows 25% rise in Revenues stands at $1.0 Million but EPS remains negative at -$14.99. View the full earnings release here.
Earnings : HTG Molecular Losses Up $HTGM Read More »
OPKO Health, Inc., has submitted the a New Drug Application (NDA) for oral Rayaldee to the U.S. Food and Drug Administration (FDA). The Rayaldree would be Indicated for the treatment of secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. View the full release here.
News: OPKO submits SHPC Drug at FDA $OPKO Read More »
Mesa Laboratories, Inc.. a firm focusing on quality control products, has announced its first quarter 2015 results. The results shows 18% rise in Revenues to $18.56 million YoY, whereas EPS went up to $2.93 at 6% YoY. View the full earnings release here.
Earnings: Mesa Labs Revenues Up $MLAB Read More »
